Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
about
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapyGM-CSF gene-modifed cancer cell immunotherapies: of mice and men.Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humansThe effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancerDexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies.Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat.Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.Pharmacologic and chemical adjuvants in tumor virotherapy.Evasion of host defences by tumours.Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus.The differential sensitivity of rat peripheral blood T cells to immunosuppressants: cyclophosphamide and dexamethasone.
P2860
Q24612603-D05F8F57-C0B7-4D2F-9BF7-B26E936E7F26Q33282703-0A27EF8C-2C80-4EAC-B486-5D0107669503Q34591128-FF731F39-E7FA-4973-A453-2AAE965FA26DQ35807040-D0547C4F-027D-40D3-8B9A-24FFC8E5360BQ35856375-C380013A-07E7-4860-8F6A-58C35233584AQ35863904-92AF616B-D896-446D-BA35-EB90734D6666Q36138929-F1E0FFC4-BAE0-4328-AFE3-3A83416F5578Q36821113-6A3DDEDE-2A6A-403C-B85F-6318264EFDF8Q36985956-22C3E197-6173-4A95-8E52-0F185C09296BQ37442739-6129364E-A4A7-4258-8DC4-86A600BB34A7Q37492540-19369B26-D2D1-4C4F-B03E-6732F03DAE09Q39679313-DB2FCC90-EC44-4531-94B1-FC96FD024D3BQ40327515-0D56085F-AC2E-4DF4-BE68-6A7C29D86745Q42063211-499D468D-458C-432A-BFE9-0119EB13E1D7Q54507757-478B8D1D-CF50-4381-A236-0E4EAFE10823
P2860
Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Augmentation of specific immun ...... T cells with cyclophosphamide.
@en
type
label
Augmentation of specific immun ...... T cells with cyclophosphamide.
@en
prefLabel
Augmentation of specific immun ...... T cells with cyclophosphamide.
@en
P1433
P1476
Augmentation of specific immun ...... T cells with cyclophosphamide.
@en
P2093
P304
P356
10.1016/0008-8749(79)90128-X
P577
1979-12-01T00:00:00Z